BACKGROUND Re-examination system was post-marketing safety measures for drugs in Korea. The objective of this study was to examine experts’ opinions for post-authorization study and current status of quality control of study in pharmaceutical company to improve the quality of post-authorization study of re-examination. METHODS We conducted mail survey for pharmaceutical company (2014. 9. 15-10. 17) and e-mail survey for experts (2014. 10. 1-10. 17). Questionnaires for 29 pharmaceutical companies and for 19 experts were collected and analyzed. RESULTS More than 80% of experts said that quality control of post-authorization study is needed to improve the study, however, many pharmaceutical companies had a difficulty in conducting study. Seventy two percent of companies pointed out low cooperation of survey sites as difficulty in monitoring of post-authorization study. CONCLUSION Quality control of post-authorization study of re-examination system needs to be improved to provide reliable evidence for drug safety.
목차
Abstract 연구방법 1. 조사대상 2. 조사방법 및 조사내용 3. 통계분석 연구결과 1. 응답자의 특성 2. 재심사대상의약품의 시판 후 조사(사용성적조사 등)의 질 관리 3. 재심사대상의약품의 시판 후 조사 시 어려운 점 고찰 감사의 말씀 참고문헌 부록
키워드
Re-examinationpost-authorization studyquality control
저자
박은자 [ Eunja Park | 한국보건사회연구원 ]
Corresponding author
한국보건사회약료경영학회 [Korean Academy of Social & Managed Care Phemacy]
설립연도
2009
분야
의약학>약학
소개
본 학회는 비영리 학술단체로서 환자의 삶의 질 향상을 위한 약료(pharmaceutical care)가 보장될 수 있도록 약료경영약학(managed care pharmacy)을 발전시키는 데 궁극 목적을 두고 다음과 같은 활동을 전개하여 사회에 기여하며 회원 상호간의 친목을 도모한다.
간행물
간행물명
한국보건사회약료경영학회지 [Journal of Korean Academy of Managed Care Pharmacy]